Addresses significant unmet need to identify benign lung nodules, with high probability, to avoid unnecessary invasive procedures. Clinical validation was based on the PANOTPIC clinical trial, a large prospective lung nodule clinical trial. Data supported a CMS coverage determination finalized in July 2017 SEATTLE, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Integrated Diagnostics today announced the e-publication of full results of a large prospective clinical trial validating its Xpresys Lung 2 ® in...